Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Michael Sperling MD

Michael R. Sperling MD

Baldwin Keyes Professor of Neurology, Thomas Jefferson University, Philadelphia, Pennsylvania

Michael R. Sperling, MD, is Baldwin Keyes Professor of Neurology and Vice Chair for Research at the Sidney Kimmel Medical College at Thomas Jefferson University, and Director of the Jefferson Comprehensive Epilepsy Center.

He is an internationally recognized clinician-scientist in the field of epilepsy, known particularly for his work in clinical neurophysiology, epilepsy surgery, and investigational therapeutics. He has published approximately 500 peer-reviewed papers, reviews, and book chapters, and several books.

He is presently Editor-in-Chief of Epilepsia and is a former president of the American Clinical Neurophysiology Society and the Philadelphia Neurological Society. He received the J. Kiffin Penry award from the American Epilepsy Society in 2018 and the Ambassador for Epilepsy award from the International League Against Epilepsy in 2021.

Disclosures

Michael Sperling has received compensation for speaking at CME programs from Medscape, Projects for Knowledge, International Medical Press, and Darnitsa. He has consulted for Medtronic, Neurelis, and Johnson & Johnson. He has received research support from Medtronic; Neurelis; SK Life Science; Takeda; Xenon; Cavion; Cerevel; UCB Pharma; Janssen; Equilibre; and Engage Pharmaceuticals. He has received royalties from Oxford University Press and Cambridge University Press.